IL0011015349
IL0011015349
CELLCOM ISRAEL LTD
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 65/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±41.1% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).
Beta (Market Relation)
0.52x
DefensiveVolatility (5Y p.a.)
41.1% p.a.
5-Year HorizonMax Drawdown (5Y)
-57.2%
5-Year HorizonSharpe Ratio
0.55
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +2.1% |
| 3 Years | 37.5% | -27.8% | 1.16 | +46% |
| 5 Years | 41.1% | -57.2% | 0.55 | +25.2% |
| 10 Years | 45.1% | -82.3% | -0.02 | +1.4% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (41.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.3% in the extended horizon.